Close

ACOR Financial Facts

Total other expense (net): -4.54M
Net loss per share-basic (earnings per share): -0.28
See Full Income Statement

Other current assets: 4.86M
Property and equipment, net of accumulated depreciation: 35.78M
See Full Balance Sheet

Acorda Therapeutics, Inc. (ACOR) Earnings

  |   Expand Research on ACOR
Next EPS Date N/A EPS Growth Rate -139.7% *Last Qtr.
Average EPS % Beat Rate -188.2% Revenue Growth Rate +63.1% *Last Qtr.
Average % Move 1-Wk after EPS -8.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/6/21 Q121 -$2.46-$2.54 +$0.08$28.86M$22.15M N/A Details
3/9/22 Q421 -$0.67N/A N/A $36.97M$31.01M N/A Details
8/5/21 Q221 -$1.87-$2.09 +$0.22$31.78M$29.94M N/A Details
11/9/21 Q321 -$1.43-$1.56 +$0.13$31.45M$30.57M N/A Details
3/4/21 Q420 -$2.50-$1.48 -$1.02$38.16M$34M N/A Details
8/1/19 Q219 -$0.58-$1.06 +$0.48$50.05M$28.82M = Details
5/2/19 Q119 -$0.56-$0.94 +$0.38$44.14M$33.04M = Details
2/14/19 Q418 $0.45-$0.63 +$1.08$69.2M$48.1M = Details